MS in the Media - 6 September 2019
31 August - 6 September 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Vitamin D may protect myelin
Vitamin D may have a role in protecting myelin in people with progressive MS according to analysis of data from people on a trial of the drug ibudilast. The analysis found no link between vitamin D levels and EDSS scores, brain volume or new lesions on an MRI scan.
Source: MS News Today
MS Trust link: Vitamin D
Ozanimod trail results
Ozanimod, a potential new treatment for relapsing MS, was better than Avonex in reducing relapses according to newly published trial results. The drug also reduced new MRI lesions and the rate of brain tissue loss but didn't show any significant difference in slowing build-up of disability
Source: National MS Society (USA)
MS Trust link: Ozanimod
Tissue donations help new MS research
Podcast interview with Richard Reynolds of the MS Tissue Bank. He talks about what the Bank does and how the collection is helping research into new treatments.
Source: Guardian
MS Trust link: Organ donation
Natalie's MS journey and how it led to the Black MS Foundation, by Natalie
18 Jan 2022 - 00:00
We caught up with Natalie, Founder of the Black MS Foundation to hear about her multiple sclerosis journey and find out what led her to set up the Foundation.
MS and exercise: part one - a Q&A with physiotherapist, Henriette
14 Jan 2022 - 00:00
In this first blog in a new series, we talk to physiotherapist, Henriette who answers some common questions people with MS may have about exercising.
New study provides strong evidence for role of Epstein Barr virus as a trigger for multiple sclerosis
14 Jan 2022 - 00:00
New research has provided evidence that infection with the Epstein Barr virus acts as a trigger for people to develop MS.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.
Share
